test

BRIANNE SHERGILL

@Exome Asset Management Llc

Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.

Assets under management

The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CYTKCytokinetics Inc
Recent Activity
New Position
2.11%
$6.186M
117,166 shares@ $52.8 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
New Position
2.01%
$5.883M
132,400 shares@ $44.43 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
2%
$5.871M
829,258 shares@ $7.08 avg price
BIIBBiogen Inc
Recent Activity
New Position
1.76%
$5.146M
26,634 shares@ $193.21 avg price
LEGNLegend Biotech Corp
Recent Activity
New Position
1.57%
$4.581M
94,000 shares@ $48.73 avg price
MRSNMersana Therapeutics Inc
Recent Activity
New Position
1.52%
$4.455M
2.357M shares@ $1.89 avg price
ETNB89bio Inc
Recent Activity
New Position
1.52%
$4.449M
601,200 shares@ $7.4 avg price
AKROAkero Therapeutics Inc
Recent Activity
New Position
1.51%
$4.424M
154,200 shares@ $28.69 avg price
STOKStoke Therapeutics Inc
Recent Activity
New Position
1.48%
$4.341M
353,200 shares@ $12.29 avg price
NUVLNuvalent Inc
Recent Activity
New Position
1.4%
$4.081M
39,890 shares@ $102.31 avg price